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Abstract.  Vascular endothelial  surface-related activi- 
ties may depend on the lateral  mobility of specific cell 
surface macromolecules.  Previous studies have shown 
that cytokines induce changes in the morphology and 
surface antigen composition of vascular endothelial 
cells in vitro and at sites of immune and inflammatory 
reactions in vivo. The effects of cytokines on mem- 
brane dynamic properties have not been examined.  In 
the present study, we have used fluorescence photo- 
bleaching recovery (FPR) to quantify the effects of the 
cytokines tumor necrosis factor (TNF) and immune in- 
terferon (IFN-7) on the lateral  mobilities of class I 
major histocompatibility complex protein,  of an abun- 
dant 96,000 Mr mesenchymal cell surface glycoprotein 
(gp96), and of a phospholipid probe in cultured hu- 
man endothelial cell (HEC) membranes.  Class I pro- 
tein and gp96 were directly labeled with fluores- 
cein-conjugated monoclonal antibodies; plasma 
membrane lipid mobility was examined with the phos- 
pholipid analogue fluorescein phosphatidylethanol- 
amine (FI-PE).  In untreated,  confluent HEC mono- 
layers, diffusion coefficients were 30  x  10  -'° cm  2 s-' 
for class I protein,  14  ×  10  -'° cm  2 s-'  for gp96,  and 
80  ×  10  -'° cm  2 s-'  for FI-PE.  Fractional  mobilities 
were >80%  for each probe. Cultures treated at visual 
confluence for 3-4 d with either  100 U/ml TNF or 
200 U/ml IFN-7 did not exhibit significant changes in 
protein or lipid mobilities despite significant changes 
in cell morphology and  membrane antigen composi- 
tion.  In HEC cultures treated concomitantly with TNF 
and IFN-7, however, diffusion coefficients decreased 
by 71-79%  for class I protein,  29-55%  for gp96, and 
23-38%  for FI-PE.  Fractional mobilities were un- 
changed.  By immunoperoxidase transmission  electron 
microscopy, plasma membranes of untreated and 
cytokine-treated HEC were flat and stained uniformly 
for class I antigen.  "Line" FPR measurements on dou- 
bly treated HEC demonstrated isotropic diffusion of 
class I protein,  gp96,  and FI-PE.  Finally, although 
TNF and IFN-T retarded the growth of HEC cultures 
and disrupted the organization  of cell monolayers, the 
slow diffusion rates of gp96 and FI-PE in confluent 
doubly treated monolayers were not reproduced in 
sparse or subconfluent untreated monolayers.  We con- 
clude that the slowing of protein and lipid diffusion in- 
duced by the combination of TNF and IFN-7 is not 
due to plasma membrane corrugations,  to anisotropic 
diffusion barriers,  or to decreased numbers of cell-cell 
contacts.  We propose that cytokines act directly to 
regulate the mobility of membrane molecules in 
confluent HEC monolayers. 
T 
HE vascular  lining  forms the  interface  between the 
blood and the underlying  vessel wall and tissues.  The 
total luminal  surface area presented by human vascu- 
lar  endothelial  cell  plasma  membranes  exceeds 6,300  m  2 
(Krough,  1929).  Endothelial  surface-related  activities  in- 
clude inducible  adherence of blood cells, binding  of hor- 
mones  and  nutrients,  regulation  of the hemostatic/throm- 
botic balance,  attachment  to the basement membrane,  and 
facilitation  of immune  and  inflammatory  responses.  Ex- 
perimental  evidence suggests that each of these activities de- 
pends,  in part,  upon the quantitative  level of expression of 
specific  cell  surface  molecules  (reviewed  by  Gimbrone, 
1986). Our working  hypothesis is that these activities  also 
depend on the organization  and dynamics of specific mole- 
cules in the plasma membrane. 
Cytokines have been shown to alter the composition of the 
endothelial  cell plasma membrane in vitro.  These changes, 
collectively called "activation"  result in altered  endothelial 
cell capacities to function in hemostasis,  inflammation,  and 
immunity  (reviewed by Cotran and Pober,  1988). For exam- 
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(IFN-~,)  have each been shown to augment expression of 
class I major histocompatibility complex (MHC) antigens on 
human endothelial cells (HEC) (Pober et al., 1983; Collins 
et al., 1986), and the combination of these two agents is syn- 
ergistic for this change (Lapierre et al., 1988).  In addition, 
TNF and IFN-y each induce reorganization of cultured HEC 
monolayers. Monolayers treated at visual confluence for 3-4 d 
with either/>20 U/ml TNF or 1>16 U/nil IFN-3, assume a 
fibroblastoid organization, rearrange actin stress fibers from 
dense peripheral  bands  to longitudinal bundles,  and lose 
fibronectin from the  extracellular matrix  (Stolpen  et  al., 
1986).  The combination of TNF and IFN-y acts synergisti- 
cally at low doses to induce similar morphologic changes. At 
higher doses these cytokines act in concert to induce unique 
morphologic changes,  such as the development of highly 
elongated "dendritic" processes (Stolpen et al., 1986). Taken 
together, these results suggested that the combination of TNF 
and IFN-y might have other unique effects on HEC. 
In this report we have investigated the effects of TNF and 
IFN-y on the lateral mobility of membrane macromolecules 
in  cultured  HEC.  Fluorescence photobleaching  recovery 
(FPR) was used to quantify the mobility of class I MHC pro- 
tein and of an abundant 96,000 Mr cell surface glycoprotein 
(gp96), each labeled with a directly fluoresceinated monoclo- 
nal antibody (mAb), and of a  fluorescent membrane lipid 
analogue. Our results show that protein and lipid mobilities 
are slowed by TNF and IFN-~, in combination, but not by ei- 
ther cytokine alone. 
Materials and Methods 
Cell Culture and Cytokine Treatment 
HEC were cultured from two to six umbilical cord veins, and passaged once 
in Medium 199 (Gibco, Grand Island, NY) supplemented with 50 p~g/ml 
endothelial cell growth factor (Meloy Laboratories, Springfield, VA), I00 gg/ 
ml porcine heparin (Sigma Chemical Co., St. Louis, MO), 20% (vol/vol) 
fetal bovine serum (Gibco), glutamine and antibiotics (M. A. Bioproducts, 
Bethesda, MD) (Gimbrone, 1976; Thornton et al., 1983).  For FPR experi- 
ments, cells were plated on 25-mm glass coverslips (Bellco Glass Co., 
Vineland, NJ); for electron microscopy, cells were plated in 24-well plastic 
dishes (Costar, Cambridge, MA). All culture surfaces were precoated with 
5-10  ~tg/cm  2 fibronecfin (Meloy  Laboratories).  Where  indicated,  HEC 
cultures at visual confluence were treated for three to four additional days 
with cytokine(s). The recombinant human cytokines used in these studies 
were TNF (expressed in Escherichia coli and purified to homogeneity; sp 
act 2.5  x  107 U/rag protein [Marmenout et al.,  1985])  and IFN-'/ (ex- 
pressed in CHO cells and partially purified; sp act 3  x  106 U/mg [Devos 
et al.,  1984];  both gifts of Prof. Walter Fiers, State University of Ghent, 
Ghent, Belgium). TNF and IFN-'t were diluted in standard growth medium 
to final concentrations of 100 U/ml (L929 cytotoxicity units [Marmenout 
et al.,  1985]) and 200 U/nil (antiviral units [Scahill et al., 1983]),  respec- 
tively. Using these cytokine treatment protocols, maximal changes in HEC 
morphology and class I antigen expression were induced (Stolpen et al., 
1986;  Pober et al.,  1986a). 
Purification of  Monoclonal Antibodies and 
Conjugation  to Fluorescein 
The murine mAb's W6/32  (reactive with class I MHC antigens [Barnstable 
1. Abbreviations used in this paper:  132M, [~2-microglobulin;  D, diffusion 
coefficient; DME  dimethylformamide; F1-PE,  fluorescein phosphatidyl- 
ethanolamine; FPR, fluorescence photobleaching recovery; G-PBS, phos- 
phate-buffered saline with 0.2%  gelatin;  gp96,  96,000  Mr glycoprotein; 
HEC,  human endothelial cell;  IFN-'y,  immune  interferon;  TNE  tumor 
necrosis factor. 
et al., 1978]) and EI/I.2 (reactive with gp96 [Pober et al., 1986a]) were each 
purified from murine ascitic fluid by 50%  saturated ammonium sulfate 
precipitation, resolubilization in and dialysis against phosphate-buffered  sa- 
line (PBS) and centrifugation at 200 g for 2 min (Mishell and Shiigi, 1980). 
The  supernatant was adjusted to pH  8.0 and  loaded onto a  protein A- 
Sepharose affinity column (Pharmacia Fine Chemicals, Piscataway,  N J) 
preequilibrated with PBS at pH 7.4.  W6/32 (subclass IgG2,) was eluted at 
pH 4.0 in 50 mM sodium acetate/40 mM sodium chloride; El/l.2 (subclass 
IgG2b) was eluted at pH 3.0 in 100 mM glycine (Ey et al.,  1978). Protein 
content was determined by optical density at 280 nm. Peak fractions were 
pooled and dialyzed extensively against 50 mM sodium carbonate/150 mM 
sodium  chloride/pH  8.5. The  dialyzed  material  was  concentrated  by 
nitrogen-driven pressure filtration (Amicon Corp., Danvers, MA) and cen- 
trifuged at 100,000 g for 1 h to remove antibody aggregates. 8-10 ml of the 
supernatant was mixed with  1/9 volume dimethylformamide (DMF) and 
stirred  at  0°C.  A  20-fold  molar  excess of fluorescein-5-isothiocyanate 
(FITC; Molecular Probes, Inc., Eugene, OR) was dissolved in 400 gl DMF 
and then added dropwise over 15 rain to the mAb/DMF solution (adapted 
from Golding [1976]).  Reactants were stirred for an additional 2.5 h in the 
dark at room temperature. Unreacted FITC was removed by gel filtration 
chromatography on a Biogel P-6 (Bio-Rad Laboratories, Richmond, CA) 
column using 50 mM potassium phosphate/pH 8.0 as the elution buffer 
(Golding, 1976). Protein and fluorescein content were determined by optical 
density at 280 and 493 nm, respectively. Fractions in the first peak were 
pooled. The FITC:mAb molar ratio was 5.6 for W6/32 and 7.2 for El/1.2, 
compared to a ratio of < 3 for commercially obtained FITC-conjugated anti- 
[~2-microglobulin  (anti-[32M;  Becton-Dickinson,  Mountain  View,  CA). 
Fluoresceinated mAhs were sterile filtered (0.22  p.m pore size; Coming 
Glass Works, Coming, NY), aliquoted, and stored at  -20°C. 
Labeling of  HEC with Fluorescent  Antibodies 
and a Lipid Analogue 
Cell  surface  class  I  MHC  proteins  were  labeled  with  either  FITC- 
conjugated anti-l~2M (subclass IgG0, FITC-conjugated W6/32,  or FITC- 
conjugated monovalent F,b fragments of W6/32 (W6/32-Fab; a gift of Dr. 
Steven Herrmann, Harvard Medical School, Boston, MA). gp96 was la- 
beled with FITC-conjugated El/1.2 (Pober et al., 1986a).  HEC monolayers 
were washed with magnesium- and calcium-containing Hank's balanced salt 
solution (HBSS) at 37°C, preincubated for 20 min on ice with a nonbinding 
murine IgG2a mAb, washed with ice cold HBSS, incubated for 60 min on 
ice with FITC-conjugated mAb diluted 1:15 in Medium 199 (final mAb con- 
centration of 50-100 gg/ml), and washed three times with HBSS at 37°C. 
Fluorescence intensity of El/1.2 staining was unaffected by cytokine treat- 
ments, whereas that of W6/32 was increased. 
Alternatively, HEC plasma membranes were labeled with the lipid pmbc 
fluorescein phosphatidylethanolamine (FI-PE; Avanti  Polar Lipids, Inc,, 
Birmingham, AL). A  1 mg/ml solution of FI-PE in chloroform was dried 
in a rotary evaporator, brought to a final concentration of  5 p,g/ml in Medium 
199, vortexed, and sonicated until clear. Cells were incubated with FI-PE 
solution for 45-50 rain at 35°C and then washed twice with HBSS/I% bo- 
vine serum albumin (Sigma Chemical Co.) and once with HBSS alone. 
Fluorescence Photobleaching Recovery 
Our FPR apparatus and analytical methods are described in detail elsewhere 
(Golan  et  al.,  1986).  ~Spot"  FPR  is a  technique used to  quantify  the 
isotropic lateral mobility of fluorescent membrane probes (Axelrod et al,, 
1976); "line" FPR is used to detect and quantify anisotropic diffusion (Stol- 
pen et al.,  1988b).  Briefly, a Gaussian laser beam having a circular (spot 
FPR) or elliptical (line FPR) profile is focused to a waist at the sample plane 
of a  fluorescence microscope. The elliptical beam is oriented on an in- 
dividual cell either parallel or perpendicular to the long axis of  the cell (Fig. 
1). After a brief, intense photobleaching pulse (the bleaching beam), recov- 
ery of fluorescence is monitored by periodic low intensity pulses (the mea- 
suring beam).  Recovery results from the lateral diffusion of unbleached 
fluorophores into the bleached area. In line FPR, recovery is dominated by 
diffusion perpendicular to the long axis of the elliptical beam (Stolpen et 
al., 1988b).  Nonlinear least squares analysis of fluorescence recovery data 
yields both the diffusion coefficient (D) and the fraction of fluorescently la- 
beled molecules that are free to diffuse on the time scale oftbc experiment. 
The Gaussian beam radius at the sample plane was calibrated daily, as de- 
scribed (Stoipen et al., 1988a). Circular Gaussian beams had radii of 1.71- 
2.15  jtm with SD <  5%. Elliptical Gaussian beams were characterized by 
radii along both the major and minor axes (see legend to Table II for details). 
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sion by the line FPR technique. (A) Fluorescence photomicrograph 
of an elliptical Gaussian laser beam focused on a 1-gm-thick film 
of aqueous ffuorescein-5-thiosemicarbizide  (major axis =  8.7 ktm; 
minor axis  --  1.2  I~m). In line  FPR experiments  performed on 
doubly  treated  HEC,  the elliptical beam was focused on a small 
patch of fluorescently labeled membrane and then oriented either 
parallel (B) or perpendicular  (C) to the long axis of the cell. The 
membrane overlying the nucleus (n) was not used. In B, diffusion 
perpendicular  to the longitudinal actin stress fibers would be mea- 
sured;  in C, diffusion parallel  to the stress fibers would be mea- 
sured. A rotatable microscope stage was used to orient the cell with 
respect to the major axis of the elliptical beam. 
Bleaching beam power at the sample was  100-500  ~tW. The measuring 
beam power was attenuated 400-fold from this value. Bleaching pulses were 
20-30 ms in duration for spot FPR and 90-750 ms for line FPR. Measuring 
pulses were 25-200 ms in duration for protein diffusion and 5-25 ms for 
lipid diffusion. 
Diffusion was measured on a small patch of uniformly fluorescent mem- 
brane.  Regions overlying the nucleus or close to the cell periphery were 
carefully avoided. Ceils often overlapped in cytokine-treated cultures,  so 
mobility measurements on cells in these cultures were performed only in 
regions of single cell thickness. Because the Gaussian laser beams used in 
these studies diverge insignificantly across the thickness of an endothelial 
cell, FPR measurements on HEC yielded an average mobility of labeled 
molecules in apical and basal membranes. In all cases, fluorescence recov- 
ery data were well fit by an equation describing the diffusion of a single spe- 
cies, suggesting that there were no major differences  between the lateral mo- 
bilities of class I protein, gp96, or FI-PE in apical and basal membranes 
of either untreated or cytokine-treated HEC. 
Care was taken to maintain the viability of  cells during FPR experiments. 
Coverslips were mounted in a Sykes-Moore chamber (Bellco Glass, Inc., 
Vineland, NJ) with 1.1 mi of standard HEC growth medium preequilibrated 
with air/5%  CO2 and warmed to 37°C.  The chamber was mounted on a 
temperature controlled stage (E. Leitz, Inc., Rockleigh, NJ). FPR measure- 
ments were performed at 37°C. Over a 90-min period of experimentation, 
cells maintained under these conditions showed no cytopathic changes and 
the pH of the culture medium remained at 7.4. 
Immunoperoxidase Staining of Cells for 
Electron Microscopy 
HEC monolayers were washed with HBSS at 37°C, fixed for 30 min with 
2%  paraformaldehyde (Fisher Scientific Co., Pittsburgh, PA)/10  mM so- 
dium  periodate/0.75  M  lysine/37.5  mM  sodium phosphate/pH 6.2,  and 
washed three times with PBS/50 mM ammonium chloride. Fixed cells were 
washed for 30 min with PBS/0.2% gelatin (G-PBS; Fisher Scientific Co.), 
incubated for 60  min with W6/32  ascitic fluid diluted  1:100 in G-PBS, 
washed three times  in  G-PBS,  incubated  for  30  min  with peroxidase- 
conjugated rabbit anti-mouse IgG (Accurate Chemical & Scientific Corp., 
Westbury, NY) and 20% normal human serum in G-PBS, and washed again 
in G-PBS.  Monolayers were postfixed with 2%  glutaraldehyde (Electron 
Microscopy  Sciences,  Port  Washington,  PA)/0.I  M  sodium cacodylate/ 
pH 7.3 for 15 min, washed with 0.05 M Tris-HCl/pH 7.6, stained with 0.5 
mg/ml diaminobenzidine (Sigma Chemical Co.) and 0.01% hydrogen perox- 
ide in 0.05  M Tris-HC1/pH 7.6, and washed with 0.05  M  Tris-HCl/pH 7.6 
and distilled water. Monolayers were fixed in 2% aqueous osmium tetroxide 
(Electron Microscopy Sciences), dehydrated through graded ethanols, in- 
filtrated with propylene oxide (Fisher Scientific Co.)  and embedded in 
LX-112  resin (Ladd Research Industries, Inc., Burlington, VT). Sections 
were examined on a Phillips model 201 transmission electron microscope. 
A nonbinding isotype-matehed murine mAb, UPC-10, was used to demon- 
strate the specificity of immunoperoxidase staining with W6/32. 
Results 
Distribution of  Fluorescent Probes on HEC 
By  fluorescence  microscopy,  El/1.2,  W6/32,  W6/32-F~b, 
anti-~2M,  and  FI-PE were  each  uniformly distributed  on 
HEC surfaces. There was no evidence of aggregation or do- 
main formation, although the existence of microaggregates 
or microdomains could not be excluded.  Cell surface fluo- 
rescence  intensity  did  not  vary  significantly  over  the 
60-90-min period required for FPR measurements on a sin- 
gle  coverslip.  Cells  labeled  with  FI-PE exhibited  perinu- 
clear, punctate fluorescence after 1-2 h at 37°C.  These areas 
were not used in FPR experiments. 
Effects of TNF and IFN-y on Protein and 
Lipid Mobility 
Spot FPR measurements were used to quantify the lateral 
mobility of W6/32-1abeled  class  I  MHC  proteins,  E1/1.2- 
labeled gp96, and the lipid analogue F1-PE in plasma mem- 
branes  of HEC  grown  to  visual  confluence.  In  untreated 
cells, diffusion coefficients (D) for class I protein and gp96 
were 30  x  10  -1° cm  2 s  -~  and  14  ×  10  -1° cm  2  s -1,  respec- 
tively (Table I). D  for F1-PE was significantly faster, 80  × 
10  -1° cm  2 s  -I  (Table I).  Fractional  mobilities were consis- 
tently >80%  for each of the probes. HEC treated at visual 
confluence for 3-4 d with either 100 U/ml TNF or 200 U/ml 
IFN-T manifested changes in cell shape, monolayer organi- 
zation,  and class I  antigen expression,  as described previ- 
ously (Collins et al.,  1986;  Pober et al.,  1986a;  Stolpen et 
al., 1986). Singly treated HEC cultures did not, however, ex- 
hibit significant changes in the mobilities of class I protein, 
gp96,  or FI-PE (Table I).  HEC  cultures  treated concomi- 
tantly for 3-4 d  with  100  U/ml TNF and 200 U/ml IFN-T 
exhibited  a  71-79%  slowing of class I  protein mobility,  a 
29-55%  slowing of gp96 mobility, and a  23-38%  slowing 
of F1-PE mobility (Table I). Fractional mobilities remained 
consistently >80% in all doubly treated cultures. Thus, there 
was no suggestion that cytokine treatment completely im- 
mobilized any fraction of the molecules examined. 
Because doubly treated cells manifest higher surface den- 
sities of class I proteins than untreated or singly treated cells 
(Lapierre et al., 1988), increased cross-linking of these pro- 
teins by the bivalent W6/32 IgG could have been responsible 
for the observed slowing of class I protein diffusion in doubly 
treated  cultures.  HEC  were therefore  labeled  with  FITC- 
conjugated W6/32-FaD, a monovalent reagent. D  for W6/32- 
Fab on doubly treated cells was found to be 69%  less than 
that on IFN-T-treated cells (Table I). This degree of slowing 
is comparable with that measured using intact W6/32 (Table 
I).  FITC-conjugated W6/32-Fab  did  not  provide  sufficient 
fluorescence signal to examine class I protein mobility in un- 
treated or TNF-treated HEC cultures. 
The lateral mobility of class I protein on doubly treated 
HEC was also examined using FITC-conjugated anti-132M. 
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D  ×  10 ~° cm  2 s  -I 
Surface  Fluorescent  TNF and 
component  probe  Untreated  TNF  IFN-"/  IFN-~' 
Class I  MHC protein  FITC-W6/32  30  +  8*  35  _+  9  27  _+  6  6.3  5:  3.6§ 
(10)*  (10)  (11)  (14) 
Class I  MHC  protein  FITC-W6/32  29  +  4  30  _+  11  23  +  6  8.5  +  3.2§ 
(10)  (1 l)  (12)  (12) 
Class I MHC protein  FITC-W/32-Fab  ND  ND  22  +  6  6.9  +  1.7§ 
(14)  (15) 
gp96  FITC-E1/1.2  13  5:4  12  +  5  13  +  4  5.9  5:  1.4§ 
(ll)  (12)  (12)  (12) 
gp96  FITC-E1/1.2  14  +  6  18  +  7  13  _  5  10  +  411 
(ll)  (12)  (12)  (ll) 
Lipid  Fl-PE  82  +  26  70  +  17  71  +  22  51  +  15¶ 
(26)  (ll)  (15)  (14) 
Lipid  FI-PE  74 +  13  72 +  19  81  +  8  57 -l-  15"* 
(11)  (15)  (10)  (ll) 
First passage HEC were plated on fibronectin-coated glass coverslips and treated at visual confluence for three to four additional days with 100 U/ml TNF and/or 
200 U/ml IFN-~, as indicated. Data in each row of the table were obtained on the same day from a single HEC culture which had been replicate plated. D, diffusion 
coefficient; ND,  not determined.  Mean fractional  mobilities were >80%  in all experiments. 
* Mean  +  SD. 
* Number of measurements. 
§ll¶**  Significance level for difference in D values (in the same row) between IFN-'t-treated  (FITC-W6/32-Fab-labeled) or untreated (all other fluorescent labels) 
and doubly treated HEC,  as determined  by two-tailed  Student's t test.  § P  < 0.001;  II P < 0.10;  ¶ P <  0.002;  ** P <  0.02. 
D for this sample was 6.4  ±  2.3  x  10  -1° cm  ~ s  -l (mean  ± 
SD for 10 measurements), which was not significantly differ- 
ent from that obtained using FITC-conjugated W6/32 (Table 
I). FITC-conjugated anti-l~EM, obtained commercially, also 
did not provide sufficient fluorescence signal to examine un- 
treated HEC cultures. 
Electron Microscopy 
Aizenbud and Gershon (1982, 1985) have shown that mem- 
brane corrugations can cause an apparent slowing of lateral 
diffusion. This effect occurs because FPR methods measure 
only those motions orthogonal to the bleaching laser beam. 
To determine whether membrane nonplanarity was responsi- 
ble for the cytokine-induced decreases in lateral diffusion, 
we used transmission electron microscopy to examine the 
topography of HEC plasma membranes and the distribution 
of immunoperoxidase-labeled class I antigens. Plasma mem- 
branes  of both untreated  and  cytokine-treated HEC  were 
found to be flat and smooth (Fig. 2). Class I antigens were 
distributed uniformly on both the apical and basal  mem- 
branes.  There was no "ruffling" or "pitting" of the plasma 
membrane in cultures treated concomitantly with TNF and 
IFN-7 (Fig. 2 d). 
Cytokine-treated cultures exhibited characteristic features 
of activated endothelium. Cells were tall and had cytoplasms 
packed with biosynthetic organelles. TNF and IFN-'/also 
caused marked disruption of  monolayer organization. Whole 
cells and cell processes were seen to overlap one another (Fig. 
2,  c  and d).  Vascular endothelial cells at sites of delayed 
hypersensitivity reactions in vivo have been shown to exhibit 
a similar morphology (Willms-Kretschmer et al., 1967; Gra- 
ham and Shannon,  1972; Dvorak et al.,  1976; Polverini et 
al.,  1977;  Freemont and Ford,  1985). 
Line FPR Measurements on Doubly Treated HEC 
We have previously shown that actin stress fibers in doubly 
treated HEC are arranged in longitudinal, parallel bundles 
(Stolpen  et  al.,  1986).  Line  FPR  measurements  of the 
diffusion of anti-132M-labeled class I protein, E1/1.2-1abeled 
gp96, and FI-PE were performed on doubly treated HEC, to 
determine whether actin stress fibers act as a one-dimension- 
al barrier to lateral diffusion. Such a barrier could explain 
the cytokine-mediated decrease in protein mobility. Diffu- 
sion was measured along two orthogonal axes oriented paral- 
lel and perpendicular, respectively, to the long axis of the 
cell (see Fig.  1).  Neither class I protein, gp96,  nor F1-PE 
was found to diffuse anisotropically in doubly treated cells 
(Table II). 
Effects of  CeU Density on gp96 and Lipid Diffusion 
TNF and IFN-'/in combination cause marked disruption of 
HEC monolayer organization (Stolpen et al., 1986). Doubly 
treated cultures lose the tightly packed, epithelioid organiza- 
tion of confluent, untreated monolayers. Rather, the cells in 
such cultures overlap extensively as if they had lost contact 
inhibition of migration. Spaces appear between neighboring 
cells, creating multiple gaps in the monolayer. To test the hy- 
pothesis that TNF and IFN-y decrease lateral mobility in- 
directly, by decreasing the number of cell-cell contacts and 
thereby releasing cells from contact inhibition, we examined 
the effects of cell density on the mobility of gp96 and F1-PE 
in untreated HEC cultures. Table III shows that changes in 
monolayer density had no effect on the mobility of either 
gp96 or lipid in untreated cultures.  In particular,  cells in 
sparse  or  subconfluent HEC  cultures  did  not exhibit the 
slowing  of  gp96  or  lipid  diffusion  which  was  seen  in 
confluent, doubly treated cultures. 
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Protein, gp96, and FL-PE Diffusion in Doubly Treated 
HEC Membranes 
D  x  10 t° cm  2 s  -~ 
Surface  Fluorescent 
component  probe  I1"  _t_ 
Class I  MHC protein  FITC-anti-132M  7.9  +  4.3¢  8.6  +  3.5 
(11)§  (12) 
gp96  FITC-E1/1.2  7.0  +  1.8  7.5  +  2.4 
(11)  (13) 
Lipid  FI-PE  70  +  25  78  +  25 
(6)  (7) 
First passage HEC were plated on fibronectin-coated glass coverslips and treated 
at visual confluence for three to four additional days with both 100 U/ml TNF 
and 200 U/ml IFN-T. Data in each row of the table were obtained on the same 
day from a single HEC culture. D, diffusion coefficient. Mean fractional mobil- 
ities were  >83%  in all experiments.  The  l/e  2 radii  (in pm) of the elliptical 
Gaussian laser beams were (minor axis/major axis): for class 1  protein diffusion 
measurements,  1.3/10.6;  for gp96  measurements,  1.2/10.5;  for FI-PE mea- 
surements,  2.4/13.0. 
* ]1, parallel,  and __[_, perpendicular,  indicate the orientations of the elliptical 
beam with respect to the axis of HEC actin stress fibers (see Fig.  1). 
Mean  __.  SD. 
§ Number of measurements. 
Discussion 
In this report, we have shown that two endothelial cell sur- 
face proteins, class I MHC protein and gp96, diffuse rapidly 
(D  ~  30  ×  10  -~° cm  2 s  -1  and  D  ~  14  ×  10  -1° cm  2 s  -1, 
respectively) in untreated, TNF-treated, and IFN-~-treated 
HEC. Similar values for class I protein diffusion have previ- 
ously been shown for W6/32-1abeled  IFN-~t-treated  human 
dermal fibroblasts (D  =  12  ×  10  -*° cm  2 S-I; Stolpen et al., 
1988b) and W6/32-Fab-labeled B lymphoblastoid cells (D  = 
21  ×  10  -1° cm  2 s-I; Bierer et al., 1987).  The lipid analogue 
FI-PE diffuses three to five times faster than protein in un- 
treated or singly treated HEC (D --- 70-80  ×  10  -1° cm  2 s-*). 
TNF and IFN-~/in combination cause a three- to fivefold de- 
crease in the diffusion rate of W6/32- or W6/32-Fab-labeled 
class I protein and a one and one half- to twofold decrease 
in  the  diffusion rates  of gp96  and  FI-PE.  Thus,  FI-PE 
diffuses 5-10 times faster than protein in doubly treated cells. 
These data suggest that the mobility of proteins in untreated 
and singly treated HEC is partially restricted relative to that 
of lipid, and that TNF and IFN-T in combination induce fur- 
ther restriction of protein mobility. Further, these data sug- 
gest that the cytokine-mediated slowing of class I protein 
diffusion does not result from the cross-linking of surface 
proteins by the bivalent W6/32 IgG. 
TNF and IFN-T could act to restrict protein and lipid mo- 
bility through a number of different mechanisms. Cytokine- 
induced changes in membrane geometry could produce an 
apparent  slowing of lateral diffusion (Aizenbud and Ger- 
shun, 1982, 1985). Transmission electron microscopy shows, 
however, that cytokine treatment does not increase corruga- 
tion or pitting of HEC plasma membranes.  Furthermore, 
membrane nonplanarity should produce proportionate changes 
in the mobility of all diffusible membrane constituents, where- 
as the mobilities of class I protein and FI-PE decrease dis- 
proportionately after treatment with TNF and IFN-7. These 
data argue against cytokine-mediated changes in HEC mem- 
brane geometry. 
Cytoskeletal  interactions  slow  transmembrane  protein 
diffusion in  both  erythrocyte (Golan  and  Veatch,  1980; 
Sheetz et al., 1980) and lymphocyte (Henis and Elson, 1981; 
Wu et al.,  1982) membranes. It is hypothesized that steric 
interactions and/or reversible, low affinity binding of trans- 
membrane proteins to specific sites on the cytoskeletal lattice 
restrict membrane protein mobility (Nicolson, 1976; Ash et 
al., 1977; Koppel et al., 1981; Jacobson et al., 1984,  1987; 
Bourguignon et al.,  1985, 1986).  TNF and IFN-y could 
restrict the mobility of class I protein and gp96 by increasing 
steric "hindrance," by increasing the affinities of cytoskeletal- 
membrane protein interactions, or by decreasing the mean 
separation between cytoskeletal binding sites. Significant in- 
teractions between an anisotropic actin cytoskeleton and a 
mobile membrane protein should lead to anisotropic diffu- 
sion of  that protein, i.e., the cytoskeleton should act as a one- 
dimensional barrier to lateral diffusion. We have previously 
shown that rhodamine-phalloidin-stained actin stress fibers 
in TNF- and IFN-~/-treated HEC are arranged in longitudinal 
bundles which are parallel to the long axis of the cell (Stol- 
pen et al.,  1986).  Using the line FPR technique, we show 
Table IlL Effect of  Monolayer Density on gp96 and Lipid Diffusion in Untreated HEC Cultures: 
Comparison with Doubly Treated Cultures 
Untreated 
Surface  Fluorescent  TNF +  IFN-~ 
component  probe  Isolated  Subconfluent  Confluent  Confluent 
gp96  FITC-E1/I.2  10.4  +  3.4"  10.0  __  2.9  10.8  +  2.0  6.7  -I- 2.9 
(10)¢  (10)  (10)  (11) 
gp96  FITC-EI/1.2  ll.l  +  3.4  10.2  _+  3.1  10.9  5:1.9  7.2  +  3.8 
(5)  (11)  (10)  (12) 
Lipid  FI-PE  140  +  14  125+  19  139  +  14  98  +  22 
(10)  (l l)  (10)  (12) 
Lipid  FI-PE  89  +  18  ND  74  +  13  57  +  15 
(12)  (11)  (11) 
First passage  HEC  were  plated  on day  0  at the  following  densities:  isolated,  1  x  104  cells/cm2; subconffuent, 2  ×  104 cells/cm2; and confluent,  5  x  104 
cells/cm 2. Cultures were treated continuously from day  1 as indicated: doubly treated cultures received  100 U/ml TNF and 200 U/ml IFN-¥.  Spot FPR measure- 
ments were performed  on day 4.  Data in each row of the table were obtained on the same day from a single HEC culture.  Data for lipid mobility in untreated 
and doubly treated confluent cultures (data set No. 2) are reproduced from Table I. ND, not determined.  Mean fractional mobilities were >94% in all experiments. 
* Diffusion coefficient (mean  5: SD)  x  l0 ~° cm  2 s  -t. 
~t Number of measurements. 
Stolpen et al.  Tumor Necrosis Factor and Immune Interferon  785 The Journal of Cell Biology, Volume  107, 1988  786 Figure 2.  Transmission electron micrographs of immunoperoxidase-stained  cultured HEC. HEC were grown to visual confluence and 
treated for four additional days  with no additives (A), 100 U/ml TNF (B), 200 U/ml IFN-'t (C), or 100 U/ml TNF and 200 U/ml IFN-? 
(D). Class I MHC antigens were labeled with W6/32 and immunoperoxidase-conjugated  rabbit anti-mouse immunoglobulin. HEC plasma 
membrane contours are smooth and relatively flat, regardless of cytokine treatment. Class I MHC protein is detected on both apical and 
basal membranes. Bar, 0.5 ktm. 
here that class I  protein,  gp96,  and FI-PE do not diffuse 
anisotropically in doubly treated HEC. These observations 
extend our previous line FPR studies, in which class I protein 
and F1-PE were found to diffuse isotropically in HEC treated 
with IFN-? alone (Stolpen et al., 1988b). (Note that line FPR 
may fail to detect diffusion anisotropy on a much larger or 
smaller scale than the characteristic dimensions of the ellip- 
tical Gaussian laser beam.)  Apparently,  the mobilities of 
class I protein and of gp96 are not restricted by cytoskeletal 
elements containing filamentous actin.  This conclusion is 
further supported by the observation that changes in protein 
mobility are observed only in doubly treated cultures, de- 
spite the similar arrangement of actin stress fibers in singly 
and doubly treated HEC. It is possible that an isotropic, non- 
phaUoidin-staining "membrane skeleton" (Marchesi,  1985) 
restricts the mobilities of class I protein and of gp96. Alter- 
natively, these two HEC membrane proteins may not interact 
significantly with any cytoskeletal elements, consistent with 
the observations of Edidin and Zuniga (1984) (see also Liv- 
neh et al.,  1986). 
The  combination  of  IFN-y  and  TNF  induces  unique 
changes in the organization and morphology of HEC cul- 
tures (Stolpen et al.,  1986).  Doubly treated cells exhibit an 
unusual "dendritic" shape. Cell-cell contacts are markedly 
disrupted; contiguous cells no longer abut one another uni- 
formly, but are  instead interconnected by numerous thin, 
actin-containing dendritic processes. In addition, TNF and 
IFN-y have been  shown to retard  HEC  growth in culture 
(Stolpen et al.,  1986),  These observations raised the possi- 
bility that the combined actions of TNF and IFN-y on HEC 
protein  and  lipid  diffusion could  be  mediated  indirectly 
through the disruption of intercellular conununication. Here, 
we have found that untreated cultures at low cell density do 
not reproduce the slowing of gp96 or F1-PE diffusion seen 
in doubly treated cultures. TNF and IFN-y in combination 
do not appear  to alter HEC  surface dynamics simply by 
decreasing the number of cell-cell contacts. Other organiza- 
tional features of doubly treated cultures may, however, lead 
to changes in cell surface dynamics. 
Cytokines may act  through other  mechanisms  to  alter 
endothelial cell surface dynamics. For example, cytokine- 
induced changes in lipid composition or protein concentra- 
tion could increase membrane viscosity or induce lipid do- 
main formation, leading to a  decrease in lateral mobility 
(Saxton,  1982;  Metcalf et al.,  1986;  Yechiel  and Edidin, 
1987; Jacobson et al.,  1987; Golan et al.,  1988).  Alterna- 
tively, cytokines could restrict the mobilities of class I pro- 
tein, gp96, and F1-PE by promoting interactions with immo- 
bile or slowly diffusing structures in the plasma membrane. 
Finally, changes in the extracellular matrix may act to re- 
strain protein and lipid mobility (Nakache et al., 1985; Wier 
and Edidin, 1986; Edidin and Wier, 1987).  Matrix compo- 
nents of interest in HEC  cultures include fibronectin and 
glycosaminoglycans. HEC  synthesize and  deposit  a  lacy, 
fibrillar meshwork of fibronectin beneath the cell monolayer 
(Jaffe and Mosher, 1978).  TNF and IFN-y induce a loss of 
fibronectin in the extracellular matrix of cultured HEC and 
have the same effect whether used singly or in combination 
(Stolpen et al.,  1986).  These findings make it unlikely that 
extracellular fibronectin is responsible for specific restric- 
tion of protein and lipid mobility in doubly treated cultures. 
HEC cultures treated with crude lymphokine preparations 
produce a dense, glycosaminoglycan-rich extracellular ma- 
trix (Montesano et al., 1984). Interactions with extracellular 
glycosaminoglycans  may restrict the lateral mobility of class 
I protein, gp96,  and F1-PE  in HEC treated with TNF and 
IFN-? in combination. If such interactions occur they must 
be relatively weak and noncovalent, because class I protein, 
Stolpen et al,  Tumor Necrosis Factor and Immune Interferon  787 gp96,  and F1-PE all have  fractional  mobilities of >80%  in 
doubly treated  HEC. 
Is the diminished  lateral  mobility  of membrane macro- 
molecules observed in cultured  endothelium in response to 
TNF and IFN-7 likely to occur in vivo? Examination of en- 
dothelial cells in situ suggests that the vascular lining is, in 
fact, exposed to a variety  of cytokines,  including TNF and 
IFN-),.  Blood vessels at sites of immune and inflammatory 
reactions express the same activation  antigens  that are  in- 
duced by TNF and IFN-3' in vitro (Cotran and Pober,  1988). 
Furthermore, many of the specialized morphologic features 
of the endothelial lining at sites of delayed hypersensitivity 
reactions and at lymph node (i.e., "high endothelial")  ven- 
ules  (Willms-Kretschmer et al.,  1967;  Graham  and Shan- 
non, 1972; Dvorak et al., 1976; Polverini et al., 1977; Free- 
mont and Ford,  1985) may be reproduced in HEC in vitro 
by addition of IFN-), and TNF to the culture  medium (Stol- 
pen et al., 1986) and in vivo in baboons by intradermal injec- 
tion of IFN-7 and TNF (Munro et al.,  1988).  Concomitant 
exposure to more than one cytokine appears  likely to occur 
in vivo because IFN-), and lymphotoxin (and possibly TNF) 
are  produced  by  the  same  subpopulations  of  antigen- 
stimulated T lymphocytes (Tite et al.,  1985),  and secretion 
of these cytokines may well be coupled. Thus, cytokines may 
act on endothelial cells in vivo, as they do in vitro, to slow 
the mobility of plasma membrane proteins and lipids. Might 
retardation  of  lateral  diffusion  have  functional  conse- 
quences? In allogeneic graft rejection, the vascular lining has 
been shown to be a primary site of attack by cytolytic T lym- 
phocytes (CTL) (McCluskey,  1980).  Studies by Herrmann 
and Mescher  (1981) suggest  that  CTL  responses  are  aug- 
mented by irnrnobilization of class I protein on the target cell. 
Vascular endothelial cells may also serve as immune acces- 
sory cells, presenting antigen  in an MHC-restricted manner 
to T helper cells (reviewed by Pober et al., 1986b). Watts et 
al. (1984)  showed that the efficiency of foreign antigen  pre- 
sentation to cloned T cells is increased 10-fold by immobiliz- 
ing class II protein. These findings  suggest that endothelial 
cell-lymphocyte  interactions  are  perturbed  by  changes  in 
MHC protein mobility. Furthermore, these findings  suggest 
that TNF (and possibly lymphotoxin) may augment the ca- 
pacity of IFN-~,-stimulated  (i.e., class II antigen expressing) 
endothelium to present antigen to circulating T helper cells. 
In summary,  we have  shown that TNF and IFN-7 act in 
concert to slow the lateral diffusion of class I MHC protein, 
gp96, and F1-PE in cultured  HEC. The decrease in mobility 
is not caused by anisotropic diffusion barriers,  perturbation 
of surface planarity, or loss of cell contact. Our observations 
are  most consistent with the hypothesis  that cytokines act 
directly on endothelium to decrease the lateral diffusion of 
surface macromolecules. We suggest that such changes could 
influence the immune accessory functions of the cytokine- 
activated  endothelial surface in situ. 
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